Credit Suisse’s Livongo Health, Inc. Common Stock LVGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-8,500
Closed -$213K 4351
2019
Q4
$213K Buy
+8,500
New +$203K ﹤0.01% 3966

Credit Suisse's LVGO Position: Q4 2020 in Review

Credit Suisse sold out of Livongo Health, Inc. Common Stock (LVGO) in Q4 2020, closing a stake of 893,813 shares — an estimated $125M sold.

Credit Suisse first reported a position in LVGO in Q3 2019 and held it in 4 quarters. The position peaked at $125M in Q3 2020. 0 funds tracked by Wall St. Rank hold LVGO as of Q4 2020.

  • Credit Suisse reported no remaining Livongo Health, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Credit Suisse sold 893,813 Livongo Health, Inc. Common Stock shares in Q4 2020, an estimated $125M.
  • Credit Suisse first reported a position in Livongo Health, Inc. Common Stock in Q3 2019 and held it in 4 quarters.
  • Credit Suisse's Livongo Health, Inc. Common Stock position peaked at $125M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Livongo Health, Inc. Common Stock as of Q4 2020.

Based on Credit Suisse's 13F filing for Q4 2020, filed 12 Feb 2021.